Dexco Expects Non-Recurring Write-Offs to Cut 3Q26 EBITDA by BRL 190 Million

• Dexco expects non-recurring, non-cash write-offs to reduce third-quarter 2026 EBITDA by approximately BRL 190 million.
• Industrial restructuring accounts for BRL 172 million in write-offs, primarily involving fixed assets and remaining inventories in metals and sanitary ware.
• The Urussanga ceramic tile plant closure accounts for BRL 8 million; other portfolio and non-operating asset adjustments total BRL 10 million.
• The board-approved write-offs remain subject to audit committee and fiscal council evaluation, as well as external auditor review.
• Financial results scheduled for November 4, 2026, will detail the adjustments.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dexco SA published the original content used to generate this news brief on October 28, 2026, and is solely responsible for the information contained therein.